Clinical Trials Browser

Substance Withdrawal Syndrome × Dasatinib × Other hematologic neoplasm × Clear all

NCT04147533 2024-11-26

HALF

Phase 2 Active not recruiting

Other hematologic neoplasm

Substance Withdrawal Syndrome, Leukemia, Myeloid, Chronic-Phase